Test Code BMIPB Borrelia miyamotoi Detection, PCR, Blood
Ordering Guidance
This assay does not detect the Borrelia species that cause Lyme disease. If Lyme disease is suspected, order SLYME / Lyme Antibody Modified 2-Tier with Reflex, Serum.
Specimen Required
Container/Tube: Lavender top (EDTA)
Specimen Volume: 1 mL
Collection Instructions: Send whole blood specimen in original tube. Do not aliquot.
Useful For
Aiding in the diagnosis of Borrelia miyamotoi infection in conjunction with clinical findings
Preferred method for detection of B miyamotoi using blood specimens
Testing Algorithm
For more information see Acute Tick-Borne Disease Testing Algorithm.
Special Instructions
Reporting Name
Borrelia miyamotoi Detection, PCR, BSpecimen Type
Whole Blood EDTASpecimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole Blood EDTA | Refrigerated | 7 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Reference Values
Negative
Reference values apply to all ages.
Supportive Data
The following assay verification data supports the use of this assay for clinical testing.
Accuracy/Diagnostic Sensitivity and Specificity:
Clinical Samples:
Sixty-two clinical EDTA blood specimens received in the clinical laboratory for Ehrlichia/Anaplasma polymerase chain reaction (PCR) were tested using the Borrelia miyamotoi PCR assay. Results were compared to the MDH 16S rRNA TaqMan assay. In addition, 2 retrospectively identified B miyamotoi-positive specimens were confirmed by the B miyamotoi PCR assay and the MDH TaqMan assay.
Spiking studies:
To supplement the clinical specimens, negative whole blood and spinal fluid (CSF) specimens were spiked with genomic or plasmid DNA of B miyamotoi near the limit of detection and tested in a blinded fashion. The sensitivity of the PCR assay was 100% and the specificity with spiked specimens was 100%. The samples were extracted and tested in a blinded fashion.
Analytical Sensitivity/Limit of Detection:
The limit of detection is 2800 target copies/mL (5.6 target copies/mcL) of whole blood or CSF.
Analytical Specificity:
No PCR signal was obtained from the extracts of 31 bacterial, viral, parasitic, and fungal isolates from similar organisms or from organisms commonly found in the specimens tested.
Precision:
Interassay and intra-assay precision were 100%.
Reference Range:
The reference range of this assay is negative. This assay is designed to detect only species of clinical significance and is to be used for patients with a clinical history and symptoms consistent with tickborne relapsing fever. It should not be used to screen healthy patients.
Reportable Range:
This is a qualitative assay, and the results are reported as negative or positive for B miyamotoi DNA.
Day(s) Performed
Monday through Saturday
Report Available
Same day/1 to 4 daysSpecimen Retention Time
1 weekPerforming Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
87478
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
BMIPB | Borrelia miyamotoi Detection, PCR, B | 82475-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
618298 | B. miyamotoi PCR, B | 82475-5 |
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.